Petroleo Brasileiro SA Petrobras
PBR
Vale SA
VALE
Adobe
ADBE
4
Apple
AAPL
5
Microsoft
MSFT
US Stock MarketDetailed Quotes
XENE Xenon Pharmaceuticals
- 37.385
- -0.155-0.41%
Trading May 6 09:55 ET
2.86BMarket Cap-12.42P/E (TTM)
37.793High37.138Low30.75KVolume37.390Open37.540Pre Close1.15MTurnover0.04%Turnover RatioLossP/E (Static)76.59MShares46.00052wk High3.79P/B2.65BFloat Cap26.74052wk Low--Dividend TTM70.83MShs Float50.990Historical High--Div YieldTTM1.75%Amplitude2.100Historical Low37.325Avg Price1Lot Size
Xenon Pharmaceuticals Key Stats
EPS
According to the latest financial report of Xenon Pharmaceuticals, the latest earnings per share (TTM) for the company is -0.84. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Xenon Pharmaceuticals's free cash flow? The latest report shows it as -55.17M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Xenon Pharmaceuticals shows that the company's current ratio is 17.85, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Xenon Pharmaceuticals, the quick ratio is 17.66, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Xenon Pharmaceuticals? The latest ROE figure is -8.46%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Xenon Pharmaceuticals, the total asset return on investment (ROA) is -8.04%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Xenon Pharmaceuticals's latest financial report to see how their gross margin is doing - currently at 100.00%.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Xenon Pharmaceuticals, the net profit margin is -28.14K%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025